Covidien Introduces AbsorbaTack(TM) 5mm Hernia Fixation Device Featuring Absorbable Tacks In Europe

Main Category: Medical Devices / Diagnostics
Also Included In: Neurology / Neuroscience
Article Date: 16 May 2008 - 2:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, announced the European introduction of the AbsorbaTack™ 5mm absorbable mesh fixation device for hernia repair, one of the most performed surgical procedures worldwide.

The AbsorbaTack™ 5mm absorbable tacks provide strong mesh attachment to the surrounding tissues, while reducing the amount of foreign material remaining in the patient long-term. Coupling the absorbable fixation of the AbsorbaTack™ with Covidien's Parietex™ mesh, a hydrophilic polyester mesh that establishes fast intimate tissue integration, offers an appropriate clinical solution. These leading innovative products were designed in collaboration with surgeons, keeping patient comfort in mind.

"We are changing the way surgeons approach soft tissue repair," said Scott Flora, President, Surgical Devices, Covidien. "The success of this new device will strengthen Covidien's position as a market leader providing comprehensive solutions for hernia repair," added Flora.

The European launch follows a highly successful January introduction of AbsorbaTack™ in the United States. "Absorbable fixation that is as effective and easy to use as Covidien's ProTack™ is ideal." said Dr. Bruce Ramshaw MD, FACS, Associate Professor, Chief, Division of General Surgery, University of Missouri. "And since AbsorbaTack™ is a 5 millimeter device, we can use it for the laparoscopic ventral hernia as well as a laparoscopic inguinal repair," added Dr. Ramshaw. For more information on AbsorbaTack™ please visit http://www.absorbatack.com.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. With 2007 revenue of nearly $9 billion, Covidien has more than 42,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit http://www.covidien.com to learn more about our business.

http://www.covidien.com